PT. Prodia Stem Cell Indonesia

Works in Cardiovascular · Dermatology · ENT · Genetic & rare · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health

PT. Prodia Stem Cell Indonesia is a clinical trial sponsor. It has 10 active clinical trials with 263 planned participants, across 12 therapeutic areas. Since 2021 it has completed 4 trials and stopped 0 early.

Trial track record · since 2021

10Active trials263 planned participants
4Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 10 active trials

StageTrialStatus

Questions about PT. Prodia Stem Cell Indonesia

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-23.

Approve Suite is not affiliated with PT. Prodia Stem Cell Indonesia.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.